Flagship Harbor Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $628K | Hold |
6,049
| – | – | 0.03% | 422 |
|
|
2025
Q4 | $632K | Buy |
6,049
+105
| +2% | +$10.6K | 0.03% | 395 |
|
|
2025
Q3 | $550K | Hold |
5,944
| – | – | 0.02% | 472 |
|
|
2025
Q2 | $475K | Hold |
5,944
| – | – | 0.02% | 483 |
|
|
2025
Q1 | $515K | Hold |
5,944
| – | – | 0.03% | 426 |
|
|
2024
Q4 | $491K | Sell |
5,944
-2,659
| -31% | -$229K | 0.03% | 433 |
|
|
2024
Q3 | $748K | Hold |
8,603
| – | – | 0.04% | 320 |
|
|
2024
Q2 | $707K | Sell |
8,603
-51
| -0.6% | -$4.05K | 0.04% | 322 |
|
|
2024
Q1 | $694K | Hold |
8,654
| – | – | 0.04% | 308 |
|
|
2023
Q4 | $659K | Hold |
8,654
| – | – | 0.05% | 304 |
|
|
2023
Q3 | $626K | Buy |
8,654
+1
| +0% | +$77 | 0.05% | 277 |
|
|
2023
Q2 | $654K | Hold |
8,653
| – | – | 0.05% | 279 |
|
|
2023
Q1 | $658K | Hold |
8,653
| – | – | 0.06% | 295 |
|
|
2022
Q4 | $680K | Hold |
8,653
| – | – | 0.07% | 269 |
|
|
2022
Q3 | $617K | Hold |
8,653
| – | – | 0.07% | 263 |
|
|
2022
Q2 | $649K | Hold |
8,653
| – | – | 0.07% | 277 |
|
|
2022
Q1 | $689K | Hold |
8,653
| – | – | 0.07% | 285 |
|
|
2021
Q4 | $702K | Sell |
8,653
-402
| -4% | -$31.8K | 0.07% | 292 |
|
|
2021
Q3 | $729K | Hold |
9,055
| – | – | 0.08% | 272 |
|
|
2021
Q2 | $729K | Buy |
9,055
+100
| +1% | +$7.94K | 0.08% | 273 |
|
|
2021
Q1 | $706K | Buy |
8,955
+101
| +1% | +$7.88K | 0.08% | 264 |
|
|
2020
Q4 | $632K | Sell |
8,854
-100
| -1% | -$6.69K | 0.08% | 262 |
|
|
2020
Q3 | $571K | Buy |
8,954
+101
| +1% | +$6.6K | 0.08% | 235 |
|
|
2020
Q2 | $572K | Buy |
8,853
+250
| +3% | +$15.5K | 0.08% | 236 |
|
|
2020
Q1 | $473K | Hold |
8,603
| – | – | 0.09% | 205 |
|
|
2019
Q4 | $557K | Sell |
8,603
-100
| -1% | -$6.08K | 0.1% | 211 |
|
|
2019
Q3 | $493K | Hold |
8,703
| – | – | 0.1% | 215 |
|
|
2019
Q2 | $523K | Hold |
8,703
| – | – | 0.11% | 190 |
|
|
2019
Q1 | $567K | Hold |
8,703
| – | – | 0.12% | 192 |
|
|
2018
Q4 | $542K | Hold |
8,703
| – | – | 0.13% | 172 |
|
|
2018
Q3 | $631K | Hold |
8,703
| – | – | 0.12% | 187 |
|
|
2018
Q2 | $584K | Hold |
8,703
| – | – | 0.12% | 183 |
|
|
2018
Q1 | $527K | Hold |
8,703
| – | – | 0.16% | 165 |
|
|
2017
Q4 | $573K | Hold |
8,703
| – | – | 0.16% | 150 |
|
|
2017
Q3 | $580K | Hold |
8,703
| – | – | 0.19% | 144 |
|
|
2017
Q2 | $544K | Hold |
8,703
| – | – | 0.19% | 144 |
|
|
2017
Q1 | $504K | Sell |
8,703
-150
| -2% | -$8.77K | 0.19% | 144 |
|
|
2016
Q4 | $490K | Buy |
+8,853
| New | +$510K | 0.21% | 133 |
|
Other funds holding PJP
PAM
CI
Flagship Harbor Advisors's PJP Position: Q1 2026 in Review
Flagship Harbor Advisors held its Invesco Pharmaceuticals ETF (PJP) position steady in Q1 2026 at 6,049 shares worth $628K. The position accounts for 0.03% of the portfolio, ranked #422.
Flagship Harbor Advisors first reported a position in PJP in Q4 2016 and has held it in 38 quarters since. The position peaked at $748K in Q3 2024. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.
- Flagship Harbor Advisors held 6,049 shares of Invesco Pharmaceuticals ETF worth $628K as of Q1 2026.
- Flagship Harbor Advisors left its Invesco Pharmaceuticals ETF share count unchanged in Q1 2026.
- Invesco Pharmaceuticals ETF made up 0.03% of Flagship Harbor Advisors's portfolio in Q1 2026, its #422 holding.
- Flagship Harbor Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2016 and has held it in 38 quarters since.
- Flagship Harbor Advisors's Invesco Pharmaceuticals ETF position peaked at $748K in Q3 2024.
- 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.
Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.